4//SEC Filing
SINGER JACK W 4
Accession 0000891293-18-000056
CIK 0000891293other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:25 PM ET
Size
5.5 KB
Accession
0000891293-18-000056
Insider Transaction Report
Form 4
SINGER JACK W
EVP, Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2018-05-16+94,433→ 94,433 totalExercise: $4.14Exp: 2028-05-16→ Common Stock (94,433 underlying)
Footnotes (1)
- [F1]The stock options will vest in six equal semi-annual installments over a three-year period commencing on March 9, 2018 subject to continued employment with the Company through the applicable vesting dates, such that the option will be fully vested on March 9, 2021.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001204264
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:25 PM ET
- Size
- 5.5 KB